Literature DB >> 33156464

Medicaid Expansion and Low-Income Adults with Substance Use Disorders.

Mark Olfson1, Melanie Wall2,3, Colleen L Barry4,5, Christine Mauro3, Tianshu Feng3, Ramin Mojtabai4,6.   

Abstract

Problems accessing affordable treatment are common among low-income adults with substance use disorders. A difference-in-differences analysis was performed to assess changes in insurance and treatment of low-income adults with common substance use disorders following the 2014 ACA Medicaid expansion, using data from the 2008-2017 National Surveys on Drug Use and Health. Lack of insurance among low-income adults with substance use disorders in expansion states declined from 34.8% (2012-2013) to 20.0% (2014-2015) to 13.5% (2016-2017) while Medicaid coverage increased from 24.8% (2012-2013) to 48.0% (2016-2017). In nonexpansion states, lack of insurance declined from 44.8% (2012-2013) to 34.2% (2016-2017) and Medicaid coverage increased from 14.3% (2012-2013) to 23.4% (2016-2017). Treatment rates remained low and little changed. Medicaid expansion contributed to insurance coverage gains for low-income adults with substance use disorders, although persistent treatment gaps underscore clinical and policy challenges of engaging these newly insured adults in treatment.
© 2020. National Council for Behavioral Health.

Entities:  

Mesh:

Year:  2020        PMID: 33156464      PMCID: PMC8099922          DOI: 10.1007/s11414-020-09738-w

Source DB:  PubMed          Journal:  J Behav Health Serv Res        ISSN: 1094-3412            Impact factor:   1.475


  20 in total

1.  Reasons for Not Seeking Substance Use Disorder Treatment: Variations by Health Insurance Coverage.

Authors:  Mir M Ali; Judith L Teich; Ryan Mutter
Journal:  J Behav Health Serv Res       Date:  2017-01       Impact factor: 1.505

2.  The Effect of Public Insurance Expansions on Substance Use Disorder Treatment: Evidence from the Affordable Care Act.

Authors:  Johanna Catherine Maclean; Brendan Saloner
Journal:  J Policy Anal Manage       Date:  2019

3.  Lessons from early Medicaid expansions under health reform: interviews with Medicaid officials.

Authors:  Benjamin D Sommers; Emily Arntson; Genevieve M Kenney; Arnold M Epstein
Journal:  Medicare Medicaid Res Rev       Date:  2013-11-22

4.  Despite Resources From The ACA, Most States Do Little To Help Addiction Treatment Programs Implement Health Care Reform.

Authors:  Christina Andrews; Amanda Abraham; Colleen M Grogan; Harold A Pollack; Clifford Bersamira; Keith Humphreys; Peter Friedmann
Journal:  Health Aff (Millwood)       Date:  2015-05       Impact factor: 6.301

5.  Impact of Medicaid Expansion on Medicaid-covered Utilization of Buprenorphine for Opioid Use Disorder Treatment.

Authors:  Hefei Wen; Jason M Hockenberry; Tyrone F Borders; Benjamin G Druss
Journal:  Med Care       Date:  2017-04       Impact factor: 2.983

6.  Medication Treatment For Opioid Use Disorders In Substance Use Treatment Facilities.

Authors:  Ramin Mojtabai; Christine Mauro; Melanie M Wall; Colleen L Barry; Mark Olfson
Journal:  Health Aff (Millwood)       Date:  2019-01       Impact factor: 6.301

Review 7.  The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findings.

Authors:  Deborah S Hasin; Bridget F Grant
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-07-26       Impact factor: 4.328

8.  Do benefits restrictions limit Medicaid acceptance in addiction treatment? Results from a national study.

Authors:  Christina M Andrews; Colleen M Grogan; Melissa A Westlake; Amanda J Abraham; Harold A Pollack; Thomas A D'Aunno; Peter D Friedmann
Journal:  J Subst Abuse Treat       Date:  2018-02-03

9.  Estimated Prevalence of Opioid Use Disorder in Massachusetts, 2011-2015: A Capture-Recapture Analysis.

Authors:  Joshua A Barocas; Laura F White; Jianing Wang; Alexander Y Walley; Marc R LaRochelle; Dana Bernson; Thomas Land; Jake R Morgan; Jeffrey H Samet; Benjamin P Linas
Journal:  Am J Public Health       Date:  2018-10-25       Impact factor: 11.561

10.  Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees.

Authors:  Hefei Wen; Jason M Hockenberry; Harold A Pollack
Journal:  JAMA Netw Open       Date:  2018-09-07
View more
  1 in total

1.  Estimating the Prevalence of Substance Use Disorders in the US Using the Benchmark Multiplier Method.

Authors:  Ramin Mojtabai
Journal:  JAMA Psychiatry       Date:  2022-09-21       Impact factor: 25.911

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.